Abstract
Diabetes Prevention Between RAAS Inhibition and PPAR-Gamma Stimulation: The Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication (DREAM) Trial
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
